Home » VOYAGER PHARMACEUTICAL SETS IPO AT 5.9 MLN SHARES
VOYAGER PHARMACEUTICAL SETS IPO AT 5.9 MLN SHARES
Voyager Pharmaceutical Corp. on Thursday set its planned initial public offering at 5.9 million shares for between $15 and $19 per share. The biopharmaceutical company said in an amended offering document filed with the U.S. Securities and Exchange Commission that the underwriter, WR Hambrecht & Co., would have the option to buy 885,000 more shares to cover over-allotments.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May